Anonymous
Guest
Anonymous
Guest
You heard it here! Ambition finally completed and now Gilead can sell Letairis to UT, a real PAH company. Single tablet regimen on the horizon with Adcirca and Letairis. Bye bye!
Why would any company buy a drug with only a few years left? Why would Gilead sell a drug that keeps going up in sales year after year? Opsumit sucks, so I see no change. This thread is BS.